North America Contract Research Organization (CRO) Market Size and Forecast (2021 - 2031)
The North America Contract Research Organization (CRO) Market is projected to grow significantly, reaching approximately US$ 42,712.4 million by 2031, up from US$ 24,846.6 million in 2024, reflecting a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.
Executive Summary and Market Analysis
The CRO market in North America is divided into three main regions: the United States, Canada, and Mexico, with the US commanding the largest market share, followed by Canada. The growth in this sector is driven by an increasing demand for CRO services from healthcare stakeholders, government support for cost-effective healthcare solutions, strategic advancements by CROs to improve their offerings, and a burgeoning healthcare industry that requires frameworks and guidelines based on real-world data.
Strategic Insights
Market Segmentation Analysis
The CRO industry is experiencing robust growth globally, primarily due to the increasing trend of outsourcing research and development (R&D) activities by pharmaceutical, biotechnology, and medical device companies. As the healthcare sector becomes more competitive and innovation-driven, companies face pressure to expedite drug discovery processes. By outsourcing R&D to CROs, firms can leverage specialized expertise, advanced infrastructure, and global networks without incurring substantial investments. CROs provide comprehensive solutions ranging from preclinical research to clinical trials, regulatory affairs, and post-marketing surveillance, allowing sponsors to focus on their core competencies.
Discovery CROs are increasingly forming long-term strategic partnerships with pharmaceutical and biotechnology firms, academic institutions, and other CROs. These collaborations may involve co-developing drugs, joint ventures, or preferred provider agreements, enabling both parties to capitalize on each other's strengths. Such partnerships can significantly shorten the time required to bring a drug to market, potentially reducing the timeline by several months compared to traditional outsourcing methods. In the US, the drug development process typically spans 10 to 15 years and costs over US$2.5 billion, with the majority of expenses incurred during the discovery and development phases. By sharing expertise, resources, and technologies, these collaborations foster innovation, mitigate risks, and distribute research costs, positioning the market for sustained growth due to the increasing reliance on R&D outsourcing to enhance efficiency, reduce costs, and expedite the delivery of life-saving drugs to patients.
Country Insights
The North America CRO Market is segmented by country into the United States, Canada, and Mexico, with the US holding the largest market share in 2024. The US is expected to maintain its dominance due to the presence of leading CROs, a well-established healthcare industry that offers a broad scope for CRO services, and a growing trend towards outsourcing R&D and clinical trial services. CROs play a vital role in the biotechnology, pharmaceutical, and medical device sectors by providing outsourced research services that help accelerate the often lengthy and complex drug development process. The demand for faster drug development and technological advancements is rapidly transforming the CRO landscape in the US. The regulatory environment significantly influences CRO operations, with initiatives like real-time assessment allowing simultaneous data evaluation during clinical trials, which CROs manage and analyze. The number of clinical trials is on the rise, with increased investments in R&D. According to a May 2023 article from the United States National Library of Medicine, there were 437,533 clinical trials registered globally in 2023, up from 399,499 in 2022, with 140,492 (31%) registered in the US. CROs help mitigate the risks of trial delays and regulatory challenges by assisting pharmaceutical companies in navigating this complex environment, thereby contributing to market growth in the US.
Company Profiles
Key players in the North America CRO Market include Parexel International Corp, IQVIA Holdings Inc, Syneos Health Inc, Medpace Holdings Inc, Thermo Fisher Scientific (PPD Inc), ProPharma Group, Precision Medicine Group, LLC, O4 Research Ltd, Julius Clinical, Siron Clinical, Clinmark sp. z o.o., Pharmaxi LLC, Smerud Medical Research Group, and AURIGON GMBH. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.
Executive Summary and Market Analysis
The CRO market in North America is divided into three main regions: the United States, Canada, and Mexico, with the US commanding the largest market share, followed by Canada. The growth in this sector is driven by an increasing demand for CRO services from healthcare stakeholders, government support for cost-effective healthcare solutions, strategic advancements by CROs to improve their offerings, and a burgeoning healthcare industry that requires frameworks and guidelines based on real-world data.
Strategic Insights
Market Segmentation Analysis
- By Service Type: The market is categorized into Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services, with Clinical Research Services holding the largest market share in 2024.
- By Product Type: Segmented into Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others, where Biosimilars lead the market in 2024.
- By Type: The market is divided into In-house and Outsource, with Outsource being the dominant segment in 2024.
- By Application: This includes Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorders, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others, with Oncology having the largest share in 2024.
- By End User: The market is segmented into Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others, with Pharmaceutical and Biotech Companies leading in 2024.
The CRO industry is experiencing robust growth globally, primarily due to the increasing trend of outsourcing research and development (R&D) activities by pharmaceutical, biotechnology, and medical device companies. As the healthcare sector becomes more competitive and innovation-driven, companies face pressure to expedite drug discovery processes. By outsourcing R&D to CROs, firms can leverage specialized expertise, advanced infrastructure, and global networks without incurring substantial investments. CROs provide comprehensive solutions ranging from preclinical research to clinical trials, regulatory affairs, and post-marketing surveillance, allowing sponsors to focus on their core competencies.
Discovery CROs are increasingly forming long-term strategic partnerships with pharmaceutical and biotechnology firms, academic institutions, and other CROs. These collaborations may involve co-developing drugs, joint ventures, or preferred provider agreements, enabling both parties to capitalize on each other's strengths. Such partnerships can significantly shorten the time required to bring a drug to market, potentially reducing the timeline by several months compared to traditional outsourcing methods. In the US, the drug development process typically spans 10 to 15 years and costs over US$2.5 billion, with the majority of expenses incurred during the discovery and development phases. By sharing expertise, resources, and technologies, these collaborations foster innovation, mitigate risks, and distribute research costs, positioning the market for sustained growth due to the increasing reliance on R&D outsourcing to enhance efficiency, reduce costs, and expedite the delivery of life-saving drugs to patients.
Country Insights
The North America CRO Market is segmented by country into the United States, Canada, and Mexico, with the US holding the largest market share in 2024. The US is expected to maintain its dominance due to the presence of leading CROs, a well-established healthcare industry that offers a broad scope for CRO services, and a growing trend towards outsourcing R&D and clinical trial services. CROs play a vital role in the biotechnology, pharmaceutical, and medical device sectors by providing outsourced research services that help accelerate the often lengthy and complex drug development process. The demand for faster drug development and technological advancements is rapidly transforming the CRO landscape in the US. The regulatory environment significantly influences CRO operations, with initiatives like real-time assessment allowing simultaneous data evaluation during clinical trials, which CROs manage and analyze. The number of clinical trials is on the rise, with increased investments in R&D. According to a May 2023 article from the United States National Library of Medicine, there were 437,533 clinical trials registered globally in 2023, up from 399,499 in 2022, with 140,492 (31%) registered in the US. CROs help mitigate the risks of trial delays and regulatory challenges by assisting pharmaceutical companies in navigating this complex environment, thereby contributing to market growth in the US.
Company Profiles
Key players in the North America CRO Market include Parexel International Corp, IQVIA Holdings Inc, Syneos Health Inc, Medpace Holdings Inc, Thermo Fisher Scientific (PPD Inc), ProPharma Group, Precision Medicine Group, LLC, O4 Research Ltd, Julius Clinical, Siron Clinical, Clinmark sp. z o.o., Pharmaxi LLC, Smerud Medical Research Group, and AURIGON GMBH. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET LANDSCAPE
4.1 PEST Analysis
5. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Contract Research Organization (CRO) Market Revenue (US$ Million), 2024 - 2031
6.2 North America Contract Research Organization (CRO) Market Forecast and Analysis
7. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY SERVICE TYPE
7.1 Early Phase Development Services
7.1.1 Overview
7.1.2 Early Phase Development Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Clinical Research Services
7.2.1 Overview
7.2.2 Clinical Research Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Laboratory Services
7.3.1 Overview
7.3.2 Laboratory Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Post-Approval Services
7.4.1 Overview
7.4.2 Post-Approval Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
8.1 Cell and Gene Therapy
8.1.1 Overview
8.1.2 Cell and Gene Therapy: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Biosimilars
8.2.1 Overview
8.2.2 Biosimilars: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Antibody Drug Conjugates
8.3.1 Overview
8.3.2 Antibody Drug Conjugates: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY TYPE
9.1 In-house
9.1.1 Overview
9.1.2 In-house: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Outsource
9.2.1 Overview
9.2.2 Outsource: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY APPLICATION
10.1 Oncology
10.1.1 Overview
10.1.2 Oncology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Neurology
10.2.1 Overview
10.2.2 Neurology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Cardiology
10.3.1 Overview
10.3.2 Cardiology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Infectious Diseases
10.4.1 Overview
10.4.2 Infectious Diseases: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Metabolic Disorder
10.5.1 Overview
10.5.2 Metabolic Disorder: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Nephrology
10.6.1 Overview
10.6.2 Nephrology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.7 Respiratory
10.7.1 Overview
10.7.2 Respiratory: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.8 Dermatology
10.8.1 Overview
10.8.2 Dermatology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.9 Ophthalmology
10.9.1 Overview
10.9.2 Ophthalmology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.10 Hematology
10.10.1 Overview
10.10.2 Hematology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.11 Others
10.11.1 Overview
10.11.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY END USER
11.1 Pharmaceutical and Biotech Companies
11.1.1 Overview
11.1.2 Pharmaceutical and Biotech Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Medical Device Companies
11.2.1 Overview
11.2.2 Medical Device Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - COUNTRY ANALYSIS
12.1 North America
12.1.1 North America Contract Research Organization (CRO) Market Revenue and Forecast and Analysis - by Country
12.1.1.1 North America Contract Research Organization (CRO) Market Revenue and Forecast and Analysis - by Country
12.1.2.2 United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.2.2.1 United States: North America Contract Research Organization (CRO) Market Share - by Service Type
12.1.2.2.2 United States: North America Contract Research Organization (CRO) Market Share - by Product Type
12.1.2.2.3 United States: North America Contract Research Organization (CRO) Market Share - by Type
12.1.2.2.4 United States: North America Contract Research Organization (CRO) Market Share - by Application
12.1.2.2.5 United States: North America Contract Research Organization (CRO) Market Share - by End User
12.2.3.3 Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2.3.3.1 Canada: North America Contract Research Organization (CRO) Market Share - by Service Type
12.2.3.3.2 Canada: North America Contract Research Organization (CRO) Market Share - by Product Type
12.2.3.3.3 Canada: North America Contract Research Organization (CRO) Market Share - by Type
12.2.3.3.4 Canada: North America Contract Research Organization (CRO) Market Share - by Application
12.2.3.3.5 Canada: North America Contract Research Organization (CRO) Market Share - by End User
12.3.4.4 Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3.4.4.1 Mexico: North America Contract Research Organization (CRO) Market Share - by Service Type
12.3.4.4.2 Mexico: North America Contract Research Organization (CRO) Market Share - by Product Type
12.3.4.4.3 Mexico: North America Contract Research Organization (CRO) Market Share - by Type
12.3.4.4.4 Mexico: North America Contract Research Organization (CRO) Market Share - by Application
12.3.4.4.5 Mexico: North America Contract Research Organization (CRO) Market Share - by End User
13 COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 INDUSTRY LANDSCAPE
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 Parexel International Corp
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 IQVIA Holdings Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Syneos Health Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Medpace Holdings Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Thermo Fisher Scientific (PPD Inc)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 ProPharma Group
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Precision Medicine Group, LLC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 O4 Research Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Julius Clinical
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Siron Clinical
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Clinmark sp. z o.o.
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Pharmaxi LLC
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
15.13 Smerud Medical Research Group
15.13.1 Key Facts
15.13.2 Business Description
15.13.3 Products and Services
15.13.4 Financial Overview
15.13.5 SWOT Analysis
15.13.6 Key Developments
15.14 AURIGON GMBH
15.14.1 Key Facts
15.14.2 Business Description
15.14.3 Products and Services
15.14.4 Financial Overview
15.14.5 SWOT Analysis
15.14.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET LANDSCAPE
4.1 PEST Analysis
5. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Contract Research Organization (CRO) Market Revenue (US$ Million), 2024 - 2031
6.2 North America Contract Research Organization (CRO) Market Forecast and Analysis
7. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY SERVICE TYPE
7.1 Early Phase Development Services
7.1.1 Overview
7.1.2 Early Phase Development Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Clinical Research Services
7.2.1 Overview
7.2.2 Clinical Research Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Laboratory Services
7.3.1 Overview
7.3.2 Laboratory Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Post-Approval Services
7.4.1 Overview
7.4.2 Post-Approval Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
8.1 Cell and Gene Therapy
8.1.1 Overview
8.1.2 Cell and Gene Therapy: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Biosimilars
8.2.1 Overview
8.2.2 Biosimilars: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Antibody Drug Conjugates
8.3.1 Overview
8.3.2 Antibody Drug Conjugates: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY TYPE
9.1 In-house
9.1.1 Overview
9.1.2 In-house: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Outsource
9.2.1 Overview
9.2.2 Outsource: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY APPLICATION
10.1 Oncology
10.1.1 Overview
10.1.2 Oncology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Neurology
10.2.1 Overview
10.2.2 Neurology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Cardiology
10.3.1 Overview
10.3.2 Cardiology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Infectious Diseases
10.4.1 Overview
10.4.2 Infectious Diseases: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Metabolic Disorder
10.5.1 Overview
10.5.2 Metabolic Disorder: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Nephrology
10.6.1 Overview
10.6.2 Nephrology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.7 Respiratory
10.7.1 Overview
10.7.2 Respiratory: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.8 Dermatology
10.8.1 Overview
10.8.2 Dermatology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.9 Ophthalmology
10.9.1 Overview
10.9.2 Ophthalmology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.10 Hematology
10.10.1 Overview
10.10.2 Hematology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.11 Others
10.11.1 Overview
10.11.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE ANALYSIS - BY END USER
11.1 Pharmaceutical and Biotech Companies
11.1.1 Overview
11.1.2 Pharmaceutical and Biotech Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Medical Device Companies
11.2.1 Overview
11.2.2 Medical Device Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - COUNTRY ANALYSIS
12.1 North America
12.1.1 North America Contract Research Organization (CRO) Market Revenue and Forecast and Analysis - by Country
12.1.1.1 North America Contract Research Organization (CRO) Market Revenue and Forecast and Analysis - by Country
12.1.2.2 United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.2.2.1 United States: North America Contract Research Organization (CRO) Market Share - by Service Type
12.1.2.2.2 United States: North America Contract Research Organization (CRO) Market Share - by Product Type
12.1.2.2.3 United States: North America Contract Research Organization (CRO) Market Share - by Type
12.1.2.2.4 United States: North America Contract Research Organization (CRO) Market Share - by Application
12.1.2.2.5 United States: North America Contract Research Organization (CRO) Market Share - by End User
12.2.3.3 Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2.3.3.1 Canada: North America Contract Research Organization (CRO) Market Share - by Service Type
12.2.3.3.2 Canada: North America Contract Research Organization (CRO) Market Share - by Product Type
12.2.3.3.3 Canada: North America Contract Research Organization (CRO) Market Share - by Type
12.2.3.3.4 Canada: North America Contract Research Organization (CRO) Market Share - by Application
12.2.3.3.5 Canada: North America Contract Research Organization (CRO) Market Share - by End User
12.3.4.4 Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3.4.4.1 Mexico: North America Contract Research Organization (CRO) Market Share - by Service Type
12.3.4.4.2 Mexico: North America Contract Research Organization (CRO) Market Share - by Product Type
12.3.4.4.3 Mexico: North America Contract Research Organization (CRO) Market Share - by Type
12.3.4.4.4 Mexico: North America Contract Research Organization (CRO) Market Share - by Application
12.3.4.4.5 Mexico: North America Contract Research Organization (CRO) Market Share - by End User
13 COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 INDUSTRY LANDSCAPE
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 Parexel International Corp
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 IQVIA Holdings Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Syneos Health Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Medpace Holdings Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Thermo Fisher Scientific (PPD Inc)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 ProPharma Group
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Precision Medicine Group, LLC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 O4 Research Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Julius Clinical
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Siron Clinical
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Clinmark sp. z o.o.
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Pharmaxi LLC
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
15.13 Smerud Medical Research Group
15.13.1 Key Facts
15.13.2 Business Description
15.13.3 Products and Services
15.13.4 Financial Overview
15.13.5 SWOT Analysis
15.13.6 Key Developments
15.14 AURIGON GMBH
15.14.1 Key Facts
15.14.2 Business Description
15.14.3 Products and Services
15.14.4 Financial Overview
15.14.5 SWOT Analysis
15.14.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
LIST OF TABLES
Table 1. North America Contract Research Organization (CRO) Market Segmentation
Table 3. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 5. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 6. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 7. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 8. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 9. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 10. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 11. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 12. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 13. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 15. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 16. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 17. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 21. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 22. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 23. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 24. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Heat Map Analysis by Key Players
Table 1. North America Contract Research Organization (CRO) Market Segmentation
Table 3. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 5. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 6. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 7. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 8. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 9. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 10. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 11. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 12. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 13. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 15. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 16. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 17. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 21. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 22. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 23. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 24. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. North America Contract Research Organization (CRO) Market Segmentation - Country
Figure 1. PEST Analysis
Figure 4. North America Contract Research Organization (CRO) Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Contract Research Organization (CRO) Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Contract Research Organization (CRO) Market Share (%) - by Service Type, 2024 and 2031
Figure 8. Early Phase Development Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Clinical Research Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Laboratory Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Post-Approval Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. North America Contract Research Organization (CRO) Market Share (%) - by Product Type, 2024 and 2031
Figure 13. Cell and Gene Therapy: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Biosimilars: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Antibody Drug Conjugates: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. North America Contract Research Organization (CRO) Market Share (%) - by Type, 2024 and 2031
Figure 18. In-house: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Outsource: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. North America Contract Research Organization (CRO) Market Share (%) - by Application, 2024 and 2031
Figure 21. Oncology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Neurology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cardiology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Infectious Diseases: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Metabolic Disorder: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Nephrology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Respiratory: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Dermatology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Ophthalmology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hematology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. North America Contract Research Organization (CRO) Market Share (%) - by End User, 2024 and 2031
Figure 33. Pharmaceutical and Biotech Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Medical Device Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Academic and Research Institutes: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. North America Contract Research Organization (CRO) Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 38. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 40. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Company Positioning & Concentration
Figure 1. North America Contract Research Organization (CRO) Market Segmentation - Country
Figure 1. PEST Analysis
Figure 4. North America Contract Research Organization (CRO) Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Contract Research Organization (CRO) Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Contract Research Organization (CRO) Market Share (%) - by Service Type, 2024 and 2031
Figure 8. Early Phase Development Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Clinical Research Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Laboratory Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Post-Approval Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. North America Contract Research Organization (CRO) Market Share (%) - by Product Type, 2024 and 2031
Figure 13. Cell and Gene Therapy: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Biosimilars: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Antibody Drug Conjugates: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. North America Contract Research Organization (CRO) Market Share (%) - by Type, 2024 and 2031
Figure 18. In-house: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Outsource: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. North America Contract Research Organization (CRO) Market Share (%) - by Application, 2024 and 2031
Figure 21. Oncology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Neurology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cardiology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Infectious Diseases: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Metabolic Disorder: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Nephrology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Respiratory: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Dermatology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Ophthalmology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hematology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. North America Contract Research Organization (CRO) Market Share (%) - by End User, 2024 and 2031
Figure 33. Pharmaceutical and Biotech Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Medical Device Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Academic and Research Institutes: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. North America Contract Research Organization (CRO) Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 38. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 40. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Company Positioning & Concentration
